VERIFIED RESEARCH APPLICATION
FULL-TEXT VERIFIEDDHPCA-100
FEMTO
PUBLISHED RESEARCH
Development and application of in-vivo dose and time-resolved measurements for clinical application of ultra-high dose rate radiotherapy
2026 · Europe PMC · PMC13085076
ROLE IN EXPERIMENT
Transimpedance amplification
Experimental Equipment
FEMTO DHPCA-100
Oscilloscope
Research EvidenceView Original ResearchSource: Europe PMC · PMC13085076
The following sentences were extracted from the published full text as evidence of the instrument's experimental use.
The transimpedance amplifier used was a Femto DHPCA-100 operated in DC, with gain 10 5 V/A, bandwidth 14 MHz, which led to a nominal 10%–90% signal rise time due to the preamplifier of 25 ns.
70%